enow.com Web Search

  1. Ads

    related to: better alternatives to metformin for cholesterol removal

Search results

  1. Results from the WOW.Com Content Network
  2. An alternative to statins may help reduce deaths from heart disease among people with high levels of LDL, or “bad” cholesterol, new research finds.. When taken as a daily pill, bempedoic acid ...

  3. Weight Loss Injections: What You Need to Know, From ... - AOL

    www.aol.com/weight-loss-injections-know-costs...

    Though it’s considered safe, up to 30 percent of people who take metformin experience gastrointestinal side effects like nausea, vomiting, and diarrhea. Naltrexone-bupropion .

  4. Wegovy vs Ozempic: Is One Better for Weight Loss? - AOL

    www.aol.com/lifestyle/wegovy-ozempic-better...

    Wegovy. It’s FDA-approved for people with a BMI of 30 or higher or 27 or higher with at least one weight-related medical condition, like high blood pressure, type 2 diabetes or high cholesterol.

  5. Bile acid sequestrant - Wikipedia

    en.wikipedia.org/wiki/Bile_acid_sequestrant

    They are occasionally used as an adjunct to the statins as an alternative to the fibrates (another major group of cholesterol-lowering drugs), which are thought to increase the risk of rhabdomyolysis when used with statins. The bile-acid-binding resins can raise triglycerides modestly (about 5%) and cannot be used if the triglycerides are elevated.

  6. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Typical reduction in glycated hemoglobin (A1C) values for Metformin is 1.5–2.0% Metformin (Glucophage) may be the best choice for patients who also have heart failure, [10] but it should be temporarily discontinued before any radiographic procedure involving intravenous iodinated contrast, as patients are at an increased risk of lactic acidosis.

  7. Meglitinide - Wikipedia

    en.wikipedia.org/wiki/Meglitinide

    A 2020 Cochrane systematic review did not find enough evidence of reduction of all-cause mortality, serious adverse events, cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to meglitinide for the treatment of type 2 diabetes.

  1. Ads

    related to: better alternatives to metformin for cholesterol removal